FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129492896> ?p ?o ?g. }

• W2129492896 endingPage "31" @default.
• W2129492896 startingPage "24" @default.
• W2129492896 abstract "Objectives. In addition to its vasoactive effects, angiotensin II has proinflammatory properties. Angiotensin-converting enzyme (ACE) inhibitors reduce the production of angiotensin II and could therefore act as anti-inflammatory agents. Here we investigated the capacity of the ACE inhibitor quinapril to modulate inflammatory arthritis. Methods. We studied the effect of quinapril on disease activity in mice with collagen-induced arthritis (CIA). Mice received oral quinapril (10 mg/kg/day) at the time of arthritis induction (prophylaxis protocol) or at the onset of mild arthritis (therapy protocol). Concentrations of immunoglobulin G (IgG) subtypes specific for bovine Type II collagen and TNF-α were measured by enzyme-linked immunoassay. Results. Quinapril significantly diminished the activity of CIA when given as prophylaxis or therapy (prophylaxis protocol, P<0.001; therapy protocol P = 0.002). Antigen-specific IgG2a antibodies were reduced by 52% (P = 0.02) in the quinapril prophylaxis protocol. Suppression of arthritis by quinapril was associated with reduced articular expression of TNF-α by 68% (P = 0.01) in the prophylaxis protocol and 27% (P = 0.06) in the therapy protocol. Quinapril therapy also inhibited expression of splenocyte TNF-α production following lipopolysaccharide (LPS) in vitro stimulation by 59% (P = 0.02). In parallel human in vitro experiments, ACE inhibition suppressed LPS-stimulated production of TNF-α by monocytes. In order to confirm that the action of quinapril occurred predominantly through suppression of angiotensin II, parallel experiments with the angiotensin receptor antagonist candesartan cilexetil demonstrated that this agent also inhibited disease activity in CIA. Conclusions. These data suggest that angiotensin II is a mediator of chronic inflammation and that ACE inhibition may have therapeutic effects in human inflammatory arthritis." @default.
• W2129492896 created "2016-06-24" @default.
• W2129492896 creator A5014753978 @default.
• W2129492896 creator A5039857688 @default.
• W2129492896 creator A5061104834 @default.
• W2129492896 creator A5074096459 @default.
• W2129492896 creator A5086285989 @default.
• W2129492896 date "2005-01-01" @default.
• W2129492896 modified "2023-10-05" @default.
• W2129492896 title "The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis" @default.
• W2129492896 cites W1421295138 @default.
• W2129492896 cites W1489873601 @default.
• W2129492896 cites W1518310332 @default.
• W2129492896 cites W1536380002 @default.
• W2129492896 cites W1554405405 @default.
• W2129492896 cites W1584682911 @default.
• W2129492896 cites W180946569 @default.
• W2129492896 cites W1963095561 @default.
• W2129492896 cites W1965434560 @default.
• W2129492896 cites W1978087024 @default.
• W2129492896 cites W1980857453 @default.
• W2129492896 cites W1990860561 @default.
• W2129492896 cites W1991883061 @default.
• W2129492896 cites W1995728045 @default.
• W2129492896 cites W1996109225 @default.
• W2129492896 cites W1998245427 @default.
• W2129492896 cites W1998651384 @default.
• W2129492896 cites W2000563697 @default.
• W2129492896 cites W2004843485 @default.
• W2129492896 cites W2007954685 @default.
• W2129492896 cites W2018545707 @default.
• W2129492896 cites W2021336399 @default.
• W2129492896 cites W2021345753 @default.
• W2129492896 cites W2030067727 @default.
• W2129492896 cites W2031396220 @default.
• W2129492896 cites W2033199439 @default.
• W2129492896 cites W2035292279 @default.
• W2129492896 cites W2038492026 @default.
• W2129492896 cites W2041019072 @default.
• W2129492896 cites W2041334028 @default.
• W2129492896 cites W2055889289 @default.
• W2129492896 cites W2062282696 @default.
• W2129492896 cites W2063396563 @default.
• W2129492896 cites W2070641536 @default.
• W2129492896 cites W2072952396 @default.
• W2129492896 cites W2087702167 @default.
• W2129492896 cites W2092772453 @default.
• W2129492896 cites W2096491169 @default.
• W2129492896 cites W2101840353 @default.
• W2129492896 cites W2101924426 @default.
• W2129492896 cites W2115096980 @default.
• W2129492896 cites W2118202495 @default.
• W2129492896 cites W2129940350 @default.
• W2129492896 cites W2131098432 @default.
• W2129492896 cites W2138670606 @default.
• W2129492896 cites W2145450205 @default.
• W2129492896 cites W2155440953 @default.
• W2129492896 cites W2159193498 @default.
• W2129492896 cites W2160427887 @default.
• W2129492896 cites W2161310292 @default.
• W2129492896 cites W2305118939 @default.
• W2129492896 cites W2400203496 @default.
• W2129492896 cites W2412752027 @default.
• W2129492896 cites W2797597138 @default.
• W2129492896 cites W2412688178 @default.
• W2129492896 doi "https://doi.org/10.1093/rheumatology/keh398" @default.
• W2129492896 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15353612" @default.
• W2129492896 hasPublicationYear "2005" @default.
• W2129492896 type Work @default.
• W2129492896 sameAs 2129492896 @default.
• W2129492896 citedByCount "60" @default.
• W2129492896 countsByYear W21294928962012 @default.
• W2129492896 countsByYear W21294928962013 @default.
• W2129492896 countsByYear W21294928962014 @default.
• W2129492896 countsByYear W21294928962015 @default.
• W2129492896 countsByYear W21294928962016 @default.
• W2129492896 countsByYear W21294928962018 @default.
• W2129492896 countsByYear W21294928962019 @default.
• W2129492896 countsByYear W21294928962020 @default.
• W2129492896 countsByYear W21294928962021 @default.
• W2129492896 countsByYear W21294928962022 @default.
• W2129492896 countsByYear W21294928962023 @default.
• W2129492896 crossrefType "journal-article" @default.
• W2129492896 hasAuthorship W2129492896A5014753978 @default.
• W2129492896 hasAuthorship W2129492896A5039857688 @default.
• W2129492896 hasAuthorship W2129492896A5061104834 @default.
• W2129492896 hasAuthorship W2129492896A5074096459 @default.
• W2129492896 hasAuthorship W2129492896A5086285989 @default.
• W2129492896 hasBestOaLocation W21294928961 @default.
• W2129492896 hasConcept C126322002 @default.
• W2129492896 hasConcept C134018914 @default.
• W2129492896 hasConcept C170493617 @default.
• W2129492896 hasConcept C203014093 @default.
• W2129492896 hasConcept C27016395 @default.
• W2129492896 hasConcept C2776992270 @default.
• W2129492896 hasConcept C2777077863 @default.
• W2129492896 hasConcept C2779611605 @default.
• W2129492896 hasConcept C2908929049 @default.

• next